Figure 1
From: Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer
Details of patients included in the study. Number of patients recruited and excluded is shown together with those for whom index and reference standard tests were performed. Numbers of patients with recurrent/locoregional disease, visceral metastasis, bone metastasis alone or bone metastasis with visceral metastasis in lung, liver or more than one visceral site are indicated. Numbers of patients who were bisphosphonate naive, had previously received, or were currently receiving, bisphosphonates are shown.
